Off-label Pearl
By Ted Rosen, MD, FAAD, Editor-in-Chief Acitretin for blockade-induced psoriasis Immune checkpoint inhibitors (anti-PD-1 drugs) restore the anti-tumor actions of T-cells. However, by decreasing T-cell inhibition, these agents may then provoke a number of autoimmune disorders, including a worsening or induction of psoriasis. Stopping the immune checkpoint drug may be problematic, as treatment options may […]